Innocoll Biotherapeutics
Pharmaceuticals, 3813 West Chester Pike, Princeton, New Jersey, 19073, United States, 51-200 Employees
Phone Number: 14*********
Who is INNOCOLL BIOTHERAPEUTICS
Innocoll is committed to improving patient care by confronting some of todays most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare ...
Read More
-
Headquarters: 3813 West Chester Pike, Princeton, New Jersey, 19073, United States
-
Date Founded: 1985
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from INNOCOLL BIOTHERAPEUTICS
Innocoll Biotherapeutics Org Chart and Mapping
Email
Phone
Adele Imbriani
Executive Administrator to the CEO, Liaison & Project Coordinator of the Leadership Team
Similar Companies to Innocoll Biotherapeutics
Abzena
-
501-1000
-
$ 100 Million to 250 Million
Akero Therapeutics
-
11-50
-
$ 1 Million to 5 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Innocoll Biotherapeutics
Answer: Innocoll Biotherapeutics's headquarters are located at 3813 West Chester Pike, Princeton, New Jersey, 19073, United States
Answer: Innocoll Biotherapeutics's phone number is 14*********
Answer: Innocoll Biotherapeutics's official website is https://innocoll.com
Answer: Innocoll Biotherapeutics's revenue is $25 Million to $50 Million
Answer: Innocoll Biotherapeutics's SIC: 2834
Answer: Innocoll Biotherapeutics's NAICS: 325412
Answer: Innocoll Biotherapeutics has 51-200 employees
Answer: Innocoll Biotherapeutics is in Pharmaceuticals
Answer: Innocoll Biotherapeutics top competitors include: Abzena , Akero Therapeutics
Answer: Innocoll Biotherapeutics contact info: Phone number: 14********* Website: https://innocoll.com
Answer: Innocoll is committed to improving patient care by confronting some of todays most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month